NAME: KYRA LALAINE A. CERVANTES BSN 4-A DATE: 02-07-2024
CLINICAL INSTRUCTOR: Xerxes Sedenio. RN
CLASSIFICATION/ INDICATION MECHANISM ROUTE/ CONTRAINDICATION SIDE ADVERSE NURSING RESPONSIBILITY
GENERIC OF ACTION DOSE EFFECT REACTIONS NAME/BRAND NAME Generic name: Used to prevent Stimulates 10 mg Contraindicated in patients -diarrhea CNS: anxiety, -Monitor bowel sounds Metoclopramide or reduce nausea motility of IVTT hypersensitive to drug and -dizziness drowsiness. -Safety and effectiveness of drug hydrochloride and vomiting upper GI tract, in those with -feeling CV: bradycardia have not been established for from emetogenic increases lower pheochromocytoma or sleepy GI: bowel disorders, therapy lasting longer than 12 Brand name: Reglan cancer esophageal other catecholamine – nausea. weeks. chemotherapy. sphincter tone, releasing para gangliomas, Hematologic: -Monitor patient for dizziness, Therapeutic class: GI and blocks tardive dyskinesia, or agranulocytosis, headache or nervousness after stimulants dopamine metoclopramide stopped; these Pharmacologic class: receptors at the seizure. neutropenia. may indicate withdrawal. Dopamine antagonists chemoreceptor Skin: rash, urticaria. trigger zone. COLLEGE OF HEALTH SCIENCES COR JESU COLLEGE DRUG STUDY
NAME: KYRA LALAINE A. CERVANTES BSN 4-A DATE: 02-07-2024
CLINICAL INSTRUCTOR: Xerxes Sedenio. RN
CLASSIFICATION/ INDICATION MECHANISM ROUTE/ CONTRAINDICATION SIDE ADVERSE NURSING RESPONSIBILITY
GENERIC OF ACTION DOSE EFFECT REACTIONS NAME/BRAND NAME Generic name: Used as a Inhibits HMG- 40 mg Contraindicated in patients -headache CNS : insomnia -Assess patient for underlying preventive agent Atorvastatin calcium CoA reductase, 1tab OD hypersensitive to drug and -sore GI: abdominal pain causes of hypercholesteremia and for non-fatal myocardial an early (and in those with active liver throat GU: UTI obtain a baseline lipid profile. infarction, fatal Brand name: Lipitor rate- limiting) PO disease or unexplained -diarrhea Skin: rash -Watch for signs of myositis and and non-fatal stroke, step in persistent elevations of - cold like Musculoskeletal: myopathy because drug may need revascularization Therapeutic class: cholesterol transaminase levels. symptoms arthralgia, myalgia. to be discontinued. procedures, Antilipemics hospitalization for biosynthesis. congestive heart Pharmacologic class: failure and angina HMG-CoA reductase in patients with coronary heart inhibitors disease.